Roivant Sciences (ROIV) News Today $13.95 -0.13 (-0.92%) Closing price 04:00 PM EasternExtended Trading$13.88 -0.07 (-0.50%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ROIV Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences StockSeptember 14 at 6:46 AM | msn.comRoivant Sciences Ltd. $ROIV Shares Bought by AmundiSeptember 13 at 3:31 AM | marketbeat.comRoivant Sciences (ROIV) Announces US$500 Million Share Repurchase Program Amid Recent ChallengesSeptember 12 at 3:49 PM | uk.finance.yahoo.comRoivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma ListSeptember 12 at 10:48 AM | markets.businessinsider.comRoivant Sciences (NASDAQ:ROIV) Reaches New 12-Month High - Still a Buy?September 12 at 5:40 AM | marketbeat.comTeza Capital Management LLC Buys New Holdings in Roivant Sciences Ltd. $ROIVSeptember 12 at 4:53 AM | marketbeat.comRoivant Named on Fortune Media and Great Place To Work's 2025 Best Workplaces in BioPharma ListSeptember 11, 2025 | globenewswire.comL’action de Roivant Sciences atteint un sommet de 52 semaines à 14,29$September 11, 2025 | fr.investing.comRoivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for MosliciguatSeptember 11, 2025 | msn.comRoivant Sciences Sees Unusually Large Options Volume (NASDAQ:ROIV)September 11, 2025 | marketbeat.comWoodline Partners LP Sells 878,592 Shares of Roivant Sciences Ltd. $ROIVSeptember 11, 2025 | marketbeat.comZimmer Partners LP Boosts Position in Roivant Sciences Ltd. $ROIVSeptember 11, 2025 | marketbeat.comStock Traders Buy Large Volume of Call Options on Roivant Sciences (NASDAQ:ROIV)September 11, 2025 | americanbankingnews.comClearline Capital LP Buys New Stake in Roivant Sciences Ltd. $ROIVSeptember 10, 2025 | marketbeat.comTwo Seas Capital LP Lowers Holdings in Roivant Sciences Ltd. $ROIVSeptember 9, 2025 | marketbeat.comRoivant Sciences Ltd. (ROIV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comRoivant Sciences Ltd. $ROIV Shares Sold by PointState Capital LPSeptember 8, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Buy" from BrokeragesSeptember 7, 2025 | americanbankingnews.comVivek Ramaswamy Sells 194,933 Shares of Roivant Sciences (NASDAQ:ROIV) StockSeptember 6, 2025 | insidertrades.comCutter Capital Management LP Takes $13.12 Million Position in Roivant Sciences Ltd. $ROIVSeptember 6, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 1,900,000 Shares of Roivant Sciences Ltd. $ROIVSeptember 6, 2025 | marketbeat.comL’action de Roivant Sciences atteint un plus haut de 52 semaines à 13,06 USDSeptember 4, 2025 | fr.investing.comStocks With Rising Relative Strength: Roivant SciencesSeptember 4, 2025 | msn.comRoivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 4, 2025 | marketbeat.comCitigroup Initiates Coverage on Roivant Sciences (NASDAQ:ROIV)September 4, 2025 | marketbeat.comRoivant Sciences Ltd. $ROIV is ADAR1 Capital Management LLC's 3rd Largest PositionSeptember 4, 2025 | marketbeat.comPulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)September 4, 2025 | globenewswire.comRoivant Sciences (NASDAQ:ROIV) Earns Buy Rating from Analysts at CitigroupSeptember 4, 2025 | americanbankingnews.comRoivant Sciences shares six-month off-treatment data in GD patientsSeptember 4, 2025 | msn.comRoivant Sciences Ltd. (ROIV) Special Call - SlideshowSeptember 3, 2025 | seekingalpha.comRoivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease PatientsSeptember 3, 2025 | globenewswire.comPDT Partners LLC Buys 60,460 Shares of Roivant Sciences Ltd. $ROIVSeptember 3, 2025 | marketbeat.comTroluce Capital Advisors LLC Invests $7.19 Million in Roivant Sciences Ltd. $ROIVSeptember 3, 2025 | marketbeat.comCitigroup Initiates Coverage of Roivant Sciences (ROIV) with Buy RecommendationSeptember 3, 2025 | msn.comCaption Management LLC Acquires 106,323 Shares of Roivant Sciences Ltd. $ROIVSeptember 3, 2025 | marketbeat.comRoivant Sciences Ltd. $ROIV Shares Sold by Corebridge Financial Inc.September 2, 2025 | marketbeat.comNorthern Trust Corp Has $33.31 Million Stock Holdings in Roivant Sciences Ltd. $ROIVSeptember 1, 2025 | marketbeat.comSB Investment Advisers UK Ltd. Sells 204,819 Shares of Roivant Sciences Ltd. $ROIVAugust 31, 2025 | marketbeat.comRoivant Sciences Ltd. $ROIV Shares Sold by Rafferty Asset Management LLCAugust 31, 2025 | marketbeat.comAffinity Asset Advisors LLC Acquires Shares of 150,000 Roivant Sciences Ltd. $ROIVAugust 28, 2025 | marketbeat.comCandriam S.C.A. Invests $276,000 in Roivant Sciences Ltd. $ROIVAugust 27, 2025 | marketbeat.comBlackBarn Capital Partners LP Acquires 625,000 Shares of Roivant Sciences Ltd. $ROIVAugust 25, 2025 | marketbeat.comEric Venker Sells 100,000 Shares of Roivant Sciences (NASDAQ:ROIV) StockAugust 23, 2025 | insidertrades.comRep. Lisa C. McClain Purchases Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)August 23, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Position in Roivant Sciences Ltd. $ROIVAugust 22, 2025 | marketbeat.comNuveen LLC Takes $31.99 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV)August 19, 2025 | marketbeat.comSwiss National Bank Sells 22,100 Shares of Roivant Sciences Ltd. $ROIVAugust 19, 2025 | marketbeat.comTimeless Rajeev Ram wins Cincinnati Open, Vivek Ramaswamy recalls playing with USA starAugust 18, 2025 | msn.comInvesco Ltd. Increases Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)August 18, 2025 | marketbeat.comCitigroup Inc. Acquires 81,482 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)August 18, 2025 | marketbeat.com Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ROIV Media Mentions By Week ROIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼1.070.94▲Average Medical News Sentiment ROIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼187▲ROIV Articles Average Week Get the Latest News and Ratings for ROIV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Roivant Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies INSM News Today BNTX News Today TEVA News Today SMMT News Today GMAB News Today ASND News Today VTRS News Today RDY News Today QGEN News Today BBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
